
Gene knockout cell lines are generated using CRISPR-Cas9 based technology to precisely disrupt target genes, enabling functional genomics research, disease modeling, and target validation.
ZUP1 (zinc finger containing ubiquitin peptidase 1) encodes a zinc finger-containing cysteine peptidase that functions as a K63-specific deubiquitinating enzyme. ZUP1 cleaves K63-linked polyubiquitin chains within the chain rather than removing terminal ubiquitin molecules. This activity contributes to regulation of K63-linked ubiquitin signaling and is implicated in DNA repair by processing ubiquitin chains at DNA repair sites.
A human esophageal cancer cell line established from a poorly differentiated squamous cell carcinoma of the upper cervical esophagus in a 49-year-old woman after radiotherapy. KYSE-150 carries amplified c-erb-B and cyclin D1 oncogenes and has been reported to produce tumors in nude mice. The cell line has been extensively characterized and is included in large-scale cancer cell line resources.
Before delivery, each clone is authenticated by STR, tested for sterility and mycoplasma, and genotype‑verified by two‑round PCR‑sequencing. Comprehensive QC data accompany every shipment to support reproducible research.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?